AIM ImmunoTech rejects stockholder Kellner's director nominations as invalid

AIM ImmunoTech Inc.

Board determined notice from Ted D. Kellner nominating himself, Todd Deutsch, and Robert L. Chioini fails to comply with company bylaws.
Company's legal counsel sent letter detailing numerous disclosure deficiencies, including false statements about nominee qualifications and undisclosed agreements.
All three nominees concealed adverse proxy advisor recommendations; each falsely answered 'No' on related questionnaire item.
Notice fails to disclose agreements with individuals involved in prior attempted board takeover, including a convicted felon.
Company will disregard nominations at 2023 annual meeting; deadline for valid notice has passed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.